A.R.T. Advisors’s Immune Design Corp. IMDZ Stock Holding History

A.R.T. Advisors’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-27,305	Closed	-$94K	–	1897
2018 Q3	$94K	Sell	27,305 -5,762	-17%	-$21.6K	﹤0.01%	1283
2018 Q2	$150K	Buy	+33,067	New	+$132K	0.01%	1269
2017 Q4	–	Sell	-19,230	Closed	-$199K	–	1905
2017 Q3	$199K	Buy	19,230 +4,800	+33%	+$47.2K	0.01%	1138
2017 Q2	$140K	Sell	14,430 -300	-2%	-$2.1K	0.01%	1220
2017 Q1	$100K	Buy	+14,730	New	+$85.2K	﹤0.01%	1269

Other funds holding IMDZ

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

A.R.T. Advisors's IMDZ Position: Q4 2018 in Review

A.R.T. Advisors sold out of Immune Design Corp. (IMDZ) in Q4 2018, closing a stake of 27,305 shares — an estimated $94K sold.

A.R.T. Advisors first reported a position in IMDZ in Q1 2017 and held it in 5 quarters. The position peaked at $199K in Q3 2017. 64 funds tracked by Wall St. Rank hold IMDZ as of Q4 2018.

A.R.T. Advisors reported no remaining Immune Design Corp. position as of Q4 2018 after selling out during the quarter.
A.R.T. Advisors sold 27,305 Immune Design Corp. shares in Q4 2018, an estimated $94K.
A.R.T. Advisors first reported a position in Immune Design Corp. in Q1 2017 and held it in 5 quarters.
A.R.T. Advisors's Immune Design Corp. position peaked at $199K in Q3 2017.
64 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2018.

Based on A.R.T. Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.